Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 154

Results For "US"

8387 News Found

USFDA visit to Alembic Pharmaceuticals Panelav facility
Drug Approval | October 19, 2022

USFDA visit to Alembic Pharmaceuticals Panelav facility

None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable


Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants
News | October 19, 2022

Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants

He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season


Bhushan Akshikar appointed MD of GlaxoSmithKline Pharmaceuticals
People | October 18, 2022

Bhushan Akshikar appointed MD of GlaxoSmithKline Pharmaceuticals

He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry


Zydus receives tentative approval from USFDA for Roflumilast tablets
Drug Approval | October 18, 2022

Zydus receives tentative approval from USFDA for Roflumilast tablets

Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data


Zydus receives tentative approval from USFDA for Valbenazine capsules
Drug Approval | October 18, 2022

Zydus receives tentative approval from USFDA for Valbenazine capsules

Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data


PM to kick start distribution of PMJAY-MA Yojana Ayushman cards in Gujarat
Policy | October 17, 2022

PM to kick start distribution of PMJAY-MA Yojana Ayushman cards in Gujarat

50 lakh coloured Ayushman cards will be distributed to all the beneficiaries across Gujarat, at their doorstep, by National Health Authority empanelled agencies after doing e-KYC of beneficiaries


CHMP recommends conditional marketing authorization for Spesolimab for generalized pustular psoriasis flares
News | October 17, 2022

CHMP recommends conditional marketing authorization for Spesolimab for generalized pustular psoriasis flares

CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in


MoS Ayush lays foundation stone for Government Ayurveda College & Hospital at Surendranagar
News | October 17, 2022

MoS Ayush lays foundation stone for Government Ayurveda College & Hospital at Surendranagar

Government Ayurveda College & Hospital will include an infrastructure for the College and a 100 bedded hospital, hostel block for students and staff quarters.


ANDA approval from USFDA for Unichem's Extended Phenytoin Sodium Capsules
Drug Approval | October 15, 2022

ANDA approval from USFDA for Unichem's Extended Phenytoin Sodium Capsules

Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures


JB Pharma publishes its maiden sustainability report
Sustainability | October 14, 2022

JB Pharma publishes its maiden sustainability report

Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%